The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Neumann Mark since year 2005.
The trader's CIK number is 1756211.
At the time of the last reporting, Neumann Mark was the EVP, Chief Commercial Officer of Intra-cellular Therapies, Inc. .
(stock ticker symbol ITCI).
See this page for all insider trading activities at Intra-cellular Therapies, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-08||ITCI||Intra-cellular Therapies, Inc.||Option Ex||20,947||.00||0|
|2019-10-15||ITCI||Intra-cellular Therapies, Inc.||Option Ex||13,448||.00||0|
|2019-10-16||ITCI||Intra-cellular Therapies, Inc.||Sale||6,774||8.25||55,885|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Neumann Mark (EVP, Chief Commercial Officer of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.